Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHB3 | P54753 | 1/20 | 0.42 |
| ▸ | MCHR1 | Q99705 | 10/20 | 0.40 |
| ▸ | CYP26A1 | O43174 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | KCNH2 | Q12809 | 5/20 | 0.38 |
| ▸ | HRH3 | Q9Y5N1 | 4/20 | 0.38 |
| ▸ | FDFT1 | P37268 | 1/20 | 0.36 |
| ▸ | GHSR | Q92847 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL29548260 | 0.87 | EPHB3 (0.43) | EPHB3MCHR1KCNH2HRH3FDFT1 | |
| SCHEMBL29548264 | 0.86 | EPHB3 (0.45) | EPHB3MCHR1KCNH2HRH3FDFT1 | |
| SCHEMBL29548232 | 0.84 | EPHB3 (0.43) | EPHB3MCHR1KCNH2HRH3 | |
| SCHEMBL29548844 | 0.84 | EPHB3 (0.43) | EPHB3MCHR1KCNH2HRH3 | |
| SCHEMBL29548130 | 0.83 | EPHB3 (0.46) | EPHB3MCHR1KCNH2HRH3 | |
| SCHEMBL29548357 | 0.81 | EPHB3 (0.40) | EPHB3MCHR1KCNH2HRH3FDFT1 | |
| SCHEMBL29548553 | 0.81 | EPHB3 (0.48) | EPHB3MCHR1CYP3A4KCNH2HRH3 | |
| SCHEMBL29548380 | 0.80 | EPHB3 (0.47) | EPHB3MCHR1CYP3A4KCNH2HRH3 | |
| SCHEMBL29548184 | 0.80 | EPHB3 (0.47) | EPHB3MCHR1CYP3A4KCNH2HRH3 | |
| SCHEMBL29548854 | 0.79 | EPHB3 (0.48) | EPHB3MCHR1CYP3A4KCNH2HRH3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022070288-A1 | NITROGEN-CONTAINING BICYCLIC COMPOUND | 旭化成ファーマ株式会社 | 2022-04-07 | — | — | WO | disclosed |